RNS Number : 4710C
Kosmos Energy Limited
13 June 2023
 

Kosmos Energy Ltd (the "Company")
PDMR Shareholding

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES

13 June 2023

The following Persons Discharging Managerial Responsibilities ("PDMRs") have had changes in their shareholdings of Common Shares in the Company:

PDMR

Date of transaction

No. of shares vested

No. of shares granted

No. of shares sold or withheld

Roy A. Franklin

8 June 2023

0

24,964

0

Roy A. Franklin

9 June 2023

0

0

8,000

Deanna L. Goodwin

8 June 2023

0

24,964

0

Deanna L. Goodwin

9 June 2023

0

0

112,000

Sir John Douglas Kelso Grant

8 June 2023

0

24,964

0

Maria Moraeus Hanssen

8 June 2023

0

24,964

0

Adebayo O. Ogunlesi

8 June 2023

0

24,964

0

Steven M. Sterin

8 June 2023

0

24,964

0

J. Michael Stice

8 June 2023

0

24,964

0

 

The Notification of Dealing Form for each PDMR, which provides full details of the transactions outlined above, can be found below.

This notification is made in accordance with Article 19 of the EU Market Abuse Regulation.

Josh R. Marion

Vice President and Assistant Secretary


CONTACT:

Investor Relations

Jamie Buckland
+44 203 954 2831
jbuckland@kosmosenergy.com

Media Relations

Thomas Golembeski
+1-214-445-9674
tgolembeski@kosmosenergy.com

 

 

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Roy A. Franklin

b)

Position / status

Director

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Shares, par value $0.01 per share

b)

Nature of the transactions

24,964 restricted share units granted to the reporting person on June 8, 2023 under the Issuer's Long Term Incentive Plan (the "Plan") and are scheduled to vest 100% on the earlier of June 8, 2024 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.

 

Shares granted or vested

c)

Currency

USD

Price

6.81

Volume

24,964

Total

170,004.84

Shares sold or withheld

d)

Currency

USD

Price

0

Volume

0

Total

0

 

 

e)

Aggregated information 


Price

6.81

Volume

24,964

Total

170,004.84

f)

Date of the transactions

8 June 2023

g)

Place of the transaction

NYSE

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Shares, par value $0.01 per share

b)

Nature of the transactions

8,000 shares sold on June 9, 2023 to partially cover income tax liability from the vesting of restricted share units granted to the reporting person under the Plan.

Shares granted or vested

c)

Currency

USD

Price

0

Volume

0

Total

0

Shares sold or withheld

d)

Currency

USD

Price

6.80

Volume

8,000

Total

54,400

 

 

e)

Aggregated information 


Price

6.80

Volume

8,000

Total

54,400

f)

Date of the transactions

9 June 2023

g)

Place of the transaction

NYSE

 

 

 


 

 

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Deanna L. Goodwin

b)

Position / status

Director

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Shares, par value $0.01 per share

b)

Nature of the transactions

24,964 restricted share units granted to the reporting person on June 8, 2023 under the Plan and are scheduled to vest 100% on the earlier of June 8, 2024 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.

 

Shares granted or vested

c)

Currency

USD

Price

6.81

Volume

24,964

Total

170,004.84

Shares sold or withheld

d)

Currency

USD

Price

0

Volume

0

Total

0

 

 

e)

Aggregated information 


Price

6.81

Volume

24,964

Total

170,004.84

f)

Date of the transactions

8 June 2023

g)

Place of the transaction

NYSE

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Shares, par value $0.01 per share

b)

Nature of the transactions

112,000 shares sold on June 9, 2023 on the open market.  The transaction was executed in multiple trades at prices ranging from USD 6.65 to USD 6.73.  The price below of USD 6.69 reflects the weighted average purchase price.

 

Shares granted or vested

c)

Currency

USD

Price

0

Volume

0

Total

0

Shares sold or withheld

d)

Currency

USD

Price

6.69

Volume

112,000

Total

749,280

 

 

e)

Aggregated information 


Price

6.69

Volume

112,000

Total

749,280

f)

Date of the transactions

9 June 2023

g)

Place of the transaction

NYSE

 

 


 

 

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Sir John Douglas Kelso Grant

b)

Position / status

Director

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Shares, par value $0.01 per share

b)

Nature of the transactions

24,964 restricted share units granted to the reporting person on June 8, 2023 under the Plan and are scheduled to vest 100% on the earlier of June 8, 2024 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.

 

Shares granted or vested

c)

Currency

USD

Price

6.81

Volume

24,964

Total

170,004.84

Shares sold or withheld

d)

Currency

USD

Price

0

Volume

0

Total

0

 

 

e)

Aggregated information 


Price

6.81

Volume

24,964

Total

170,004.84

f)

Date of the transactions

8 June 2023

g)

Place of the transaction

NYSE

 

 


 

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Maria Moraeus Hanssen

b)

Position / status

Director

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Shares, par value $0.01 per share

b)

Nature of the transactions

24,964 restricted share units granted to the reporting person on June 8, 2023 under the Plan and are scheduled to vest 100% on the earlier of June 8, 2024 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.

 

Shares granted or vested

c)

Currency

USD

Price

6.81

Volume

24,964

Total

170,004.84

Shares sold or withheld

d)

Currency

USD

Price

0

Volume

0

Total

0

 

 

e)

Aggregated information 


Price

6.81

Volume

24,964

Total

170,004.84

f)

Date of the transactions

8 June 2023

g)

Place of the transaction

NYSE

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Adebayo O. Ogunlesi

b)

Position / status

Director

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Shares, par value $0.01 per share

b)

Nature of the transactions

24,964 restricted share units granted to the reporting person on June 8, 2023 under the Plan and are scheduled to vest 100% on the earlier of June 8, 2024 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.

 

 

Shares granted or vested

c)

Currency

USD

Price

6.81

Volume

24,964

Total

170,004.84

Shares sold or withheld

d)

Currency

USD

Price

0

Volume

0

Total

0

e)

Aggregated information 


Price

6.81

Volume

24,964

Total

170,004.84

f)

Date of the transactions

8 June 2023

g)

Place of the transaction

NYSE

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Steven M. Sterin

b)

Position / status

Director

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Shares, par value $0.01 per share

b)

Nature of the transactions

24,964 restricted share units granted to the reporting person on June 8, 2023 under the Plan and are scheduled to vest 100% on the earlier of June 8, 2024 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.

 

Shares granted or vested

c)

Currency

USD

Price

6.81

Volume

24,964

Total

170,004.84

Shares sold or withheld

d)

Currency

USD

Price

0

Volume

0

Total

0

e)

Aggregated information 


Price

6.81

Volume

24,964

Total

170,004.84

f)

Date of the transactions

8 June 2023

g)

Place of the transaction

NYSE

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

J. Michael Stice

b)

Position / status

Director

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Shares, par value $0.01 per share

b)

Nature of the transactions

24,964 restricted share units granted to the reporting person on June 8, 2023 under the Plan and are scheduled to vest 100% on the earlier of June 8, 2024 or the day immediately preceding the date of the Issuer's first annual shareholder meeting following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder.

 

Shares granted or vested

c)

Currency

USD

Price

6.81

Volume

24,964

Total

170,004.84

Shares sold or withheld

d)

Currency

USD

Price

0

Volume

0

Total

0

e)

Aggregated information 


Price

6.81

Volume

24,964

Total

170,004.84

f)

Date of the transactions

8 June 2023

g)

Place of the transaction

NYSE

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSFFFUEEDSEIM